Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation

Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells

(2016) Holly M. Jacobs et al.   JOURNAL OF IMMUNOLOGY

Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers

(2015) William A. Figgett et al.   JOURNAL OF AUTOIMMUNITY

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)

(2014) David Isenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

B Lymphocyte Stimulator Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation

(2014) S. K. Chang et al.   JOURNAL OF IMMUNOLOGY

Vaccine for Atherosclerosis

(2014) Prediman K. Shah et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE−/− Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation

(2012) Tin Kyaw et al.   PLoS One

B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions

(2011) Tin Kyaw et al.   CIRCULATION RESEARCH

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

(2011) Deborah P. M. Symmons et al.   Nature Reviews Rheumatology

Lupus Atherosclerosis Prevention Study (LAPS)

(2010) M. A. Petri et al.   ANNALS OF THE RHEUMATIC DISEASES

The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice

(2010) Yanice V. Mendez-Fernandez et al.   ATHEROSCLEROSIS

B cell depletion reduces the development of atherosclerosis in mice

(2010) Hafid Ait-Oufella et al.   JOURNAL OF EXPERIMENTAL MEDICINE

FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice

(2010) Ming Zhao et al.   JOURNAL OF IMMUNOLOGY

Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis

(2010) T. Kyaw et al.   JOURNAL OF IMMUNOLOGY

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

(2010) Cristina Anania et al.   ARTHRITIS RESEARCH & THERAPY

Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study

(2009) A. Elisabeth Hak et al.   ARTHRITIS AND RHEUMATISM

Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

(2009) Myles J. Lewis et al.   CIRCULATION

B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation

(2009) Yu-Hee Kim et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Adipocytes as Immune Cells: Differential Expression of TWEAK, BAFF, and APRIL and Their Receptors (Fn14, BAFF-R, TACI, and BCMA) at Different Stages of Normal and Pathological Adipose Tissue Development

(2009) V.-I. Alexaki et al.   JOURNAL OF IMMUNOLOGY

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact

(2008) J. L. Scholz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA